Anna Berry

Molecular Pathologist and Senior Executive with deep expertise in pathology, genomics, precision oncology, real world data, and building new services and teams.

Role
Director Molecular Pathology, Head of Next Generation Sequencing at Pfizer
Location
Seattle, WA, US
LinkedIn followers
500 followers

About Anna Berry

I have spent my entire career focused on helping cancer patients access the best possible treatment options. From my early days in cytology and fine needle aspiration biopsy services, to my extensive work in genomic oncology and molecular genetic pathology education, to my work implementing these practices in various community settings, to my forays into real world data, implementation science, and drug development, my focus has always been on extending and improving the lives of people facing a cancer diagnosis.

Experience

  1. Director Molecular Pathology, Head of Next Generation Sequencing

    Pfizer

    Dec 2024 — Present · Bothell, WA, US

    Implementation of next generation sequencing services in a CLIA environment to support clinical trials. Managing and directing NGS staff. Additionally participating as lead pathologist in study teams and IHC validation studies, as well as in digital pathology and digital image analysis projects.

Education

  • University of Wyoming

    Bachelor of Science (BS), Political Science, Chemistry minor

    1986 — 1990

  • Upstate Medical University

    Pathology Residency Program

  • National Cancer Institute, Bethesda MD

    Cytopathology Fellowship Program

  • Virginia Commonwealth University

    Molecular Genetic Pathology Fellowship Program

  • University of Nebraska Medical Center

    Doctor of Medicine (MD)

    1991 — 1995

  • Virginia Commonwealth University

    Pathology Residency Program

  • Upstate Medical University

    General Surgery Residency Program

Skills

  • Molecular Biology
  • Hospitals
  • Molecular Diagnostics
  • Fine Needle Aspiration
  • Personalized Medicine
  • Cancer
  • Molecular Oncology
  • Healthcare Management
  • Genomics Education
  • Medical Education
  • Pathology
  • Medicine
  • Precision Medicine
  • Life Sciences
  • Healthcare
  • Clinical Research
  • Oncology
  • Healthcare Information Technology
  • Immunology
  • Tumor Genomics

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Anna Berry — Director Molecular Pathology, Head of Next Generation Sequencing at Pfizer in Seattle, WA, US | Unifers